INVO Fertility, Inc.
IVFNasdaqCIK 1417926HealthcareFiscal year ends Dec 31
Reports and events: 284 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2812:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040504 |
| 2026-08-1712:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038648 |
| 2026-08-1421:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038528 |
| 2026-07-2421:20 ET | S-1 | Registration statement | 0001493152-26-034621 |
| 2026-07-2421:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-034616 |
| 2026-06-2520:52 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001493152-26-030147 |
| 2026-06-2320:05 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001493152-26-029785 |
| 2026-06-2213:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-029517 |
| 2026-06-2213:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-029514 |
| 2026-06-1621:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028910 |
| 2026-06-1220:29 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-028454 |
| 2026-06-0212:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-026777 |
| 2026-06-0212:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-026775 |
| 2026-06-0212:30 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-26-026772 |
| 2026-04-2920:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019593 |
| 2026-03-3120:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-014227 |
| 2026-02-2414:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007830 |
| 2026-02-0221:47 ET | S-1 | Registration statement | 0001493152-26-004766 |
| 2026-01-3021:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-004484 |
| 2026-01-2622:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-003628 |
| 2026-01-0621:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000592 |
| 2025-12-1821:05 ET | DEF 14A | Proxy statementPeriod 2025-12-18 | 0001493152-25-028349 |
| 2025-12-1721:42 ET | S-1 | Registration statement | 0001493152-25-028163 |
| 2025-12-1714:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028070 |
| 2025-12-0522:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026427 |
| 2025-12-0321:46 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025977 |
| 2025-11-1713:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023779 |
| 2025-11-1712:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023751 |
| 2025-10-2220:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-25-018911 |
| 2025-10-1420:45 ET | S-1 | Registration statement | 0001493152-25-018032 |
| 2025-10-1020:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-25-017752 |
| 2025-10-0320:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016850 |
| 2025-09-2921:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016076 |
| 2025-09-2621:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-015821 |
| 2025-09-1220:12 ET | 8-K | 3.02 Unregistered sale of equity | 0001641172-25-027201 |
| 2025-09-0521:29 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-026757 |
| 2025-08-2221:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001641172-25-025270 |
| 2025-08-1518:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024338 |
| 2025-08-1421:28 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024212 |
| 2025-08-0120:15 ET | 8-K | 3.02 Unregistered sale of equity | 0001641172-25-021900 |
| 2025-07-2320:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001641172-25-020699 |
| 2025-07-2120:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020406 |
| 2025-07-1012:55 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-018529 |
| 2025-07-0112:33 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-017280 |
| 2025-06-2520:43 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-016484 |
| 2025-06-0620:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001641172-25-014019 |
| 2025-06-0420:05 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001641172-25-013611 |
| 2025-05-3021:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events | 0001641172-25-013122 |
| 2025-05-2101:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011842 |
| 2025-05-2020:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011710 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.